Searched for
GLIMEPIRIDE
Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...- Supreme Court seeks Centre's response on Micro Labs' plea against diabetes drug banThe Supreme Court has asked the Centre and the Drug Controller General of India to respond to Micro Labs' appeal against a ban on two fixed...
- Delhi HC restores ban on 2 diabetes FDCsThe Delhi High Court has made waves with its recent judgment, reinstating a ban on two fixed-dose combination drugs for managing Type II Di...
- 'Stop selling, stocking, or using': List of drugs and cosmetic banned by KarnatakaThe Karnataka government has banned 15 drugs and cosmetic products deemed "Not of Standard Quality" after failing quality tests at the stat...
- NPPA revises ceiling prices of 128 formulationsThe National Pharmaceutical Pricing Authority (NPPA) has also fixed the retail price of 12 scheduled formulations under Drugs (Prices Contr...
- NPPA fixes price caps for 12 anti-diabetic medicinesThese include glimepiride tablet of strength 1 mg, with ceiling price at Rs 3.6 per tablet, while that for 2 mg is Rs 5.72 per tablet. The ...
- Drug pricing regulator fixes prices of 40 formulation drugsThe regulator has reduced the maximum retail price of a new class of drugs, including statins, diabetes drugs, cardiovascular and combinati...
- Government regulation led to increase in price of essential drugs: Economic SurveyPrices of those formulations, under price control, sold in hospitals increased as much as Rs 99 per mg, while those formulations which were...
- Branded heart, diabetes drugs much costlier than generic onesIn the diabetes drugs segment the average price of leading brands of some medicines is also higher between 10-3 times the MRP of generic dr...
- Medicines for diabetes, infections to cost 40 per cent lessMedicines widely used to treat diabetes, infections, pain and digestive disorders will cost 5-40 per cent less with immediate effect
- Medicines for diabetes, infections to cost 40% lessMedicines widely used to treat diabetes, infections, pain and digestive disorders will cost 5-40 per cent less with immediate effect.
- NPPA brings 39 more drugs under price controlThe prices of formulations including Ciprofloxacin Hydrochloride, Cefotaxime, Paracetamol, Domperidone and Metformin+Glimepiride have been ...
- NPPA fixes price of 39 drug formulation packsAs per the notification the prices of formulations including Ciprofloxacin Hydrochloride, Cefotaxime, Paracetamol, Domperidone and Metformi...
- NPPA caps prices of 43 drug formulation packs"The prices have been fixed / revised in respect of 43 formulation packs, both ceiling and retail price packs, under DPCO, 2013," NPPA said.
- NPPA order may not impact much, seeking legal advice: Dr Reddy'sDrug pricing regulator NPPA has fixed the price of 108 non-scheduled formulation packs of 50 anti-diabetes and cardiac medicines.
- Sanofi India shares tank over 10% on price control orderSanofi India's stock tanked 10.22 per cent to settle at Rs 2,900. In intra-day trade, the scrip plunged 10.99 per cent to Rs 2,875.
- Prices of 108 diabetes, cardiac formulations fixed: NPPAThe drugs that will become cheaper would include atorvastatin, gliclazide, glimepiride, heparin and metolazone among others.
- Anti-diabetic drug tops India's pharma salesIn a grim reminder of the rise of lifestyle diseases, anti-diabetic molecule has for the first time become the largest-selling formulation ...
- Diabetes drug ban to help companies like USV, Sun Pharma, LupinIn the wake of a government ban on top-selling diabetes drug, pioglitazone , the volumes are expected to shift to other classes such as fir...
- Aventis Pharma, Themis sign tech dealAventis Pharma and Themis Laboratories have signed a technology transfer agreement for fixed-dose combinations comprising glibenclamide (Da...
Load More
